From the year 1988 to 1991, Dr. Siegall worked at the National Institutes of Health, after that joining the Bristol – Myers Squibb Pharmaceutical Research Institute and the National Cancer Institute, working there for six years. He reflected back to his many years of experience that entailed rigorous research, innovation, and passion for helping people motivated him to start the Seattle Genetics in 1998 where he currently serves as the President, CEO, and the Chairperson on the Board of Directors.
To add to his many duties his at Seattle Genetic, Dr. Siegall also renders his service as a member Board of Director both at Alder Biopharmaceuticals, which is a private owned biotechnology institution, and Mirma Therapeutic. He is also actively involved in the board of governors for Fred Hutchinson Cancer Research Centers.At Seattle Genetics, he spearheaded the development of Antibody Drug Conjugates (ADC) and tirelessly worked towards the approval of its ADC product, ADCETRIS (brentuximabvedotin) by the FDA in the year 2011. The success of it is evident and is widespread to over 65 countries globally.
Dr. Siegall pursued his Bachelor of Science degree in Zoology at the University of Maryland and after that attended The George Washington University for his Ph.D. in Genetics. CrunchBase, BusinessWire, exome blogsshow his collaborative leadership trait that is exemplary and admirable; he has propelled the company into numerous strategic licenses for its successful ADC technology. Companies included in this agreement include; Roche, GlaxoSmithKline, Pfizer, and Abbvie, generating upto 350 million dollars from these alliances. The company is also diversifying to come up with other ADC for the treatment of Cancer, a disease on the rise globally. Seattle Genetics currently has about 20 clinical ADC trials under the genetic technology pioneered by Dr. Siegall. Recently the company released its financial performance report for the first quarter, ending March 31, 2017, and it is a reflection how well it is doing.
His remarkable contribution both to Seattle Genetics and other institution over the years has seen him bag a number of awards which include Maryland University Alumnus of the Year in 2013 for Math, Computer and Natural Sciences. The previous year he had had the opportunity of being awarded Pacific Northwest Ernst & Young Entrepreneur of the Year award. Over and above, Dr. Clay Siegall has authored many books, holding 15 copyrights for his work.